Siren, L.L.C. Pro Qr Therapeutics N.V. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Siren, L.L.C. holds 1,552,183 shares of PRQR stock, worth $3.69 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,552,183
Previous 1,552,183
-0.0%
Holding current value
$3.69 Million
Previous $2.06 Billion
53.38%
% of portfolio
0.16%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
63Shares Held
41.2MCall Options Held
26KPut Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.6MShares$15.7 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$11.9 Million1.92% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.5MShares$8.33 Million1.2% of portfolio
-
Morgan Stanley New York, NY3.08MShares$7.34 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.08MShares$4.94 Million2.02% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $170M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...